341 related articles for article (PubMed ID: 28840829)
1. Transglutaminase 2 in human diseases.
Szondy Z; Korponay-Szabó I; Király R; Sarang Z; Tsay GJ
Biomedicine (Taipei); 2017 Sep; 7(3):15. PubMed ID: 28840829
[TBL] [Abstract][Full Text] [Related]
2. Transglutaminase 2: an enigmatic enzyme with diverse functions.
Fesus L; Piacentini M
Trends Biochem Sci; 2002 Oct; 27(10):534-9. PubMed ID: 12368090
[TBL] [Abstract][Full Text] [Related]
3. Some lessons from the tissue transglutaminase knockout mouse.
Sarang Z; Tóth B; Balajthy Z; Köröskényi K; Garabuczi E; Fésüs L; Szondy Z
Amino Acids; 2009 Apr; 36(4):625-31. PubMed ID: 18584284
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the development of tissue transglutaminase (TG2) inhibitors.
Badarau E; Collighan RJ; Griffin M
Amino Acids; 2013 Jan; 44(1):119-27. PubMed ID: 22160259
[TBL] [Abstract][Full Text] [Related]
5. The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.
Kotsakis P; Wang Z; Collighan RJ; Griffin M
Amino Acids; 2011 Oct; 41(4):909-21. PubMed ID: 21046178
[TBL] [Abstract][Full Text] [Related]
6. The Role of Tissue Transglutaminase in Cancer Cell Initiation, Survival and Progression.
Tabolacci C; De Martino A; Mischiati C; Feriotto G; Beninati S
Med Sci (Basel); 2019 Jan; 7(2):. PubMed ID: 30691081
[TBL] [Abstract][Full Text] [Related]
7. Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.
Carbone C; Di Gennaro E; Piro G; Milone MR; Pucci B; Caraglia M; Budillon A
Amino Acids; 2017 Mar; 49(3):517-528. PubMed ID: 27761756
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting Transglutaminase 2 Mediates Kidney Fibrosis via Anti-Apoptosis.
Moon JJ; Choi Y; Kim KH; Seo A; Kwon S; Kim YC; Kim DK; Kim YS; Yang SH
Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740367
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of fibronectin and tissue transglutaminase promotes cell invasion involving increased association with integrin and MMP expression in A431 cells.
Chen SH; Lin CY; Lee LT; Chang GD; Lee PP; Hung CC; Kao WT; Tsai PH; Schally AV; Hwang JJ; Lee MT
Anticancer Res; 2010 Oct; 30(10):4177-86. PubMed ID: 21036738
[TBL] [Abstract][Full Text] [Related]
10. Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects.
Paolella G; Lepretti M; Barone MV; Nanayakkara M; Di Zenzo M; Sblattero D; Auricchio S; Esposito C; Caputo I
Amino Acids; 2017 Mar; 49(3):541-550. PubMed ID: 27613408
[TBL] [Abstract][Full Text] [Related]
11. Transglutaminase 2 is dispensable but required for the survival of mice in dextran sulfate sodium-induced colitis.
Jeong EM; Son YH; Choi Y; Kim JH; Lee JH; Cho SY; Kim IG
Exp Mol Med; 2016 Nov; 48(11):e267. PubMed ID: 27811936
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis.
Tatsukawa H; Kojima S
Cell Biol Int; 2010 Feb; 34(3):325-34. PubMed ID: 20192918
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminase 2: Friend or foe? The discordant role in neurons and astrocytes.
Quinn BR; Yunes-Medina L; Johnson GVW
J Neurosci Res; 2018 Jul; 96(7):1150-1158. PubMed ID: 29570839
[TBL] [Abstract][Full Text] [Related]
14. An unprecedented dual antagonist and agonist of human Transglutaminase 2.
Yi MC; Palanski BA; Quintero SA; Plugis NM; Khosla C
Bioorg Med Chem Lett; 2015 Nov; 25(21):4922-4926. PubMed ID: 26004580
[TBL] [Abstract][Full Text] [Related]
15. Transglutaminase 2 strongly binds to an extracellular matrix component other than fibronectin via its second C-terminal beta-barrel domain.
Stamnaes J; Cardoso I; Iversen R; Sollid LM
FEBS J; 2016 Nov; 283(21):3994-4010. PubMed ID: 27685605
[TBL] [Abstract][Full Text] [Related]
16. Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells.
Herman JF; Mangala LS; Mehta K
Oncogene; 2006 May; 25(21):3049-58. PubMed ID: 16449978
[TBL] [Abstract][Full Text] [Related]
17. New insights into the functions and localization of nuclear transglutaminase 2.
Kuo TF; Tatsukawa H; Kojima S
FEBS J; 2011 Dec; 278(24):4756-67. PubMed ID: 22051117
[TBL] [Abstract][Full Text] [Related]
18. Tissue transglutaminase: from biological glue to cell survival cues.
Mehta K; Fok JY; Mangala LS
Front Biosci; 2006 Jan; 11():173-85. PubMed ID: 16146723
[TBL] [Abstract][Full Text] [Related]
19. Feline chronic kidney disease is associated with upregulation of transglutaminase 2: a collagen cross-linking enzyme.
Sánchez-Lara AC; Elliott J; Syme HM; Brown CA; Haylor JL
Vet Pathol; 2015 May; 52(3):513-23. PubMed ID: 25047228
[TBL] [Abstract][Full Text] [Related]
20. Transglutaminase 2 interacts with syndecan-4 and CD44 at the surface of human macrophages to promote removal of apoptotic cells.
Nadella V; Wang Z; Johnson TS; Griffin M; Devitt A
Biochim Biophys Acta; 2015 Jan; 1853(1):201-12. PubMed ID: 25449226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
